Femto Technologies Inc.

BYND Cannasoft Enterprises, Inc. engages in construction, licensing and operation of the cannabis farm. It also develops new CRM platform and new cannabis CRM platform. The company was founded on July 19, 2019 and is headquartered in Vancouver, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Femto Technologies, Inc. develops, markets and sells a proprietary client relationship management software known as Benefit CRM and Cannabis CRM platform. It also develops the EZ-G device, a patent-pending device that, combined with proprietary software. The company was founded on March 29, 2021 and is headquartered in Kiryat Motzkin, Israel.

Flora Growth Corp

Fort Lauderdale, Florida--(Newsfile Corp. - September 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Harold Wolkin as an independent director on its Board of Directors. In this role, Mr.

Flora Growth Corp. Appoints Harold Wolkin to Board of Directors; Clifford Starke Named Chairman

NEW YORK, NY / ACCESSWIRE / March 18, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN)

Toronto, Ontario--(Newsfile Corp. - Le 14 mars/March 2024) - The common shares of BYND Cannasoft Enterprises Inc. will be delisted from the CSE at market close today, March 14, 2024. The common shares currently trade on Nasdaq.

CSE Bulletin: Delist - BYND Cannasoft Enterprises Inc. (BYND)

Israeli Technology Company BYND Cannasoft Enterprises EZ-G Project Team is in Shenzen, China, to solidify agreements with two large manufacturers to produce its EZ-G Device and EZ-G Capsules Israeli Technology Company BYND Cannasoft Enterprises EZ-G Project Team is in Shenzen, China, to solidify agreements with two large manufacturers to produce its EZ-G Device and EZ-G Capsules

BYND Cannasoft Entering Production Agreements for its EZ-G Device

NEW YORK, NY / ACCESSWIRE / December 21, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN)

Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries

Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today on submitting a research and development plan based on a planned budget of US$1.5 million (grant of up to US$0.75 million) to develop CRM software combined with AI for the medical cannabis industry (File number 82745 – Application number 01125047). Israel's Finance Ministry recently clarified its decision to increase the wartime high-tech sector fund to provide short- and long-term measures designed to assist startup companies in Israel's high-tech sector. The Company was found suitable for submitting the application according to the criteria required in the grant program as detailed on the Israel Innovation Authority website.

Israel's Finance Ministry Increases Israel Innovation Authority's High-Tech Sector Fast-Track Fund to $100 Million During Wartime

ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2,000 new patients in just one month, approaching the peak numbers of 2021 and bringing the total number to over 132,000 as of November 2023. BYND Cannasoft's proprietary Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management. Benefit CRM is provisioned as SaaS to some of Israel's most recognizable companies.

Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”) has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Second Quarter 2023 Financial Results

ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future.

BYND Cannasoft CEO Delivers Update Amidst Promising Milestones

The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023 The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023

Israeli Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device

ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction.

BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023

NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.

Aegis Capital Corp. Acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN)

ASHKELON, Israel and VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately US$2.6 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 1,733,334 common shares at a price to the public of US$1.50 per share. The Company intends to use the net proceeds from this offering primarily for product design and manufacturing, sales and marketing campaigns, patent prosecution and working capital.

BYND Cannasoft Closes US$2.6 Million Underwritten Public Offering

ASHKELON, Israel and VANCOUVER, British Columbia, July 17, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately US$2.6 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consists of 1,733,334 common shares at a price to the public of US$1.50 per share. The Company intends to use the net proceeds from this offering for working capital.

BYND Cannasoft Announces Pricing of US$2.6 Million Underwritten Public Offering

BYND Cannasoft Enterprise (NASDAQ: BCAN ) stock is dropping on Monday after the company announced an underwritten stock offering. BYND Cannasoft Enterprise announced the underwritten offering after markets closed on Friday.

Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?

Shares of BYND Cannasoft Enterprises Inc. BCAN, -0.45% shares dropped in the extended session Friday after the cannabis business software company said it was issuing a secondary offering. BYND Cannasoft shares fell 19% after hours, following a 0.5% rise to close Friday at $3.12.

BYND Cannasoft stock drops on announced secondary offering

ASHKELON, Israel and VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced that it intends to offer its securities in a firm commitment underwritten public offering. The Company intends to use the net proceeds from this offering for working capital. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

BYND Cannasoft Announces Proposed Underwritten Public Offering

ASHKELON, Israel and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the successful completion of the laboratory testing phase aimed at optimizing the various sensors in its innovative EZ-G device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, has shown promise in releasing low concentrations of CBD oils, including hemp seed oil and other natural oils, to potentially address specific women's health issues.

BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization

BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed U.S. Provisional Patent Application 63461609 on April 25, 2023 covering the mechanical structure, operation, and controlling aspects of a treatment device monitored by sensors and capable of stimulating the male sexual organs based on user preferences

U.S. Patent filed by BYND Cannasoft to Expand its Artificial Intelligence and Machine Learning Algorithm to a Male Treatment Device

BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. received a positive opinion from the examiner of the PCT for its method that enables its AI-based device to identify a level of satisfaction according to parameters received from the device sensors BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. received a positive opinion from the examiner of the PCT for its method that enables its AI-based device to identify a level of satisfaction according to parameters received from the device sensors

The Patent Cooperation Treaty (PCT) Provides Positive Opinion on BYND Cannasoft's AI-Based Female Treatment Device

Plans to formulate proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel in its AI based device and EZ-G device Plans to formulate proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel in its AI based device and EZ-G device

Multinational BYND Cannsoft to Utilize Israeli License for Its EZ-G Smart Cartridges Using Artificial intelligence (AI) Software to Individualize Each Dose

BYND Cannasoft Enterprises (NASDAQ: BCAN ) stock is on the rise Thursday after the company revealed a patent for AI tech in the U.S. The patent has to do with a device for treating certain phenomena in female sexual organs. The company notes that this patent is connected to its plan to break into the multibillion-dollar Sextech Industry.

Why Is BYND Cannasoft (BCAN) Stock Up 10% Today?

BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed US Provisional Patent Application 63/450,503 on March 7, 2023 covering the mechanical structure, operation, and controlling aspects of an additional smart female treatment device BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed US Provisional Patent Application 63/450,503 on March 7, 2023 covering the mechanical structure, operation, and controlling aspects of an additional smart female treatment device

U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the Multibillion-Dollar Sextech Industry

The new full scale PCT application for the EZ-G device, comprised of a structure and one or more moving and vibrating elements, will utilize Artificial Intelligence (AI) to send data about learned sexual preferences to the cloud to heighten arousal, and intimacy The new full scale PCT application for the EZ-G device, comprised of a structure and one or more moving and vibrating elements, will utilize Artificial Intelligence (AI) to send data about learned sexual preferences to the cloud to heighten arousal, and intimacy

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device

News for Femto Technologies Inc. Stock (BCAN)